Scientific, ethical, and regulatory considerations are key when designing human challenge trials.
View More The past, present, and future of human challenge trials
Category: Healthcare
The future of treating aging
As our population ages, our medical institutions may need to re-evaluate the status quo.
View More The future of treating aging
Biogen’s Aduhelm controversy as a case study for accelerated approval biomarkers in Alzheimer’s and related diseases
The recent FDA Biogen controversy sheds light on the future of drug approval in America.
View More Biogen’s Aduhelm controversy as a case study for accelerated approval biomarkers in Alzheimer’s and related diseases
Biosecurity risks and governance in the age of synthetic biology
The rapid pace of biotechnology development poses real and alarming biosecurity risks.
View More Biosecurity risks and governance in the age of synthetic biology
On innovation in public health across government, industry, and academia
Conversations on innovation in public health in response to crises.
View More On innovation in public health across government, industry, and academia